Stock Market Reviews

CODX (Co-Diagnostics, Inc.) News

Get the latest news, insights, and market updates on CODX (Co-Diagnostics, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia
  Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will host a virtual fireside chat on Wednesday, November 5, 2025 at 11:00 am ET.
  Oct 30, 2025 - $CODX
• Sector Update: Health Care Stocks Fall Late Afternoon
  Health care stocks were lower late Wednesday afternoon, with the NYSE Health Care Index decreasing 0
  Oct 29, 2025 - $CODX
• Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
  Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of its previously announced offering of 12,727,272 shares of common stock (or pre-funded warrants in-lieu thereof) at an offering price of $0.55 per share (the "Offering").
  Oct 29, 2025 - $CODX
• Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
  Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into a securities purchase agreement with several institutional investors for the purchase and sale of 12,727,272 shares of common stock (or pre-funded warrants in-lieu thereof) at an offering price of $0.55 per share, in a registered direct offering priced at-the-market under Nasdaq
  Oct 28, 2025 - $CODX
• Trending tickers: Amazon, Qualcomm, Tesla, Co-Diagnostics and Qorvo
  The latest investor updates on stocks that are trending on Tuesday
  Oct 28, 2025 - $CODX
• BC-Most Active Stocks
  td class="col-issue">New Era Energy & Digital Inc.
  Oct 27, 2025 - $CODX
• EXCLUSIVE: Co-Diagnostics Inks JV With Saudi Arabia Firm For Middle East Market
  Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of Saudi Arabia (KSA) based Arabian Eagle Manufacturing. The agreement aims to research, develop, manufacture, assemble, distribute, and commercialize Co-Dx technologies and intellectual property, including the company's upcoming Co-Dx PCR point-of-care platform in KSA and 18 other countries across the Middle East and North Africa regions. The financial terms of the JV were
  Oct 27, 2025 - $CODX
• Sector Update: Health Care Stocks Softer Monday Afternoon
  Health care stocks edged down Monday afternoon, with the NYSE Health Care Index and the Health Care
  Oct 27, 2025 - $CODX
• Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx™ PCR Platform Across the Middle East
  Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into a definitive agreement with Arabian Eagle Manufacturing ("Arabian Eagle"), a regional manufacturing and distribution company based in the Kingdom of Saudi Arabia ("KSA") to form a joint venture ("JV"), CoMira Diagnostics ("CoMira"), to research, develop, manufacture, assemble, d
  Oct 27, 2025 - $CODX
• Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia
  Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that members of the Company's executive leadership team will be in attendance and host a booth at Global Health Exhibition 2025 at the Riyadh Exhibition & Convention Center on October 27-30 in Riyadh, Kingdom of Saudi Arabia (KSA).
  Oct 22, 2025 - $CODX